Two Postdocs on Tissue Microstructure Imaging and Diffusion and One Postdoc on AI-based qMR for tumor prediction

Our research focuses on the development and clinical translation of novel quantitative Magnetic Resonance Imaging (MRI) technology, to improve the understanding, diagnosis and treatment of diseases.

Clinical decisions currently rely heavily on invasive procedures, such as biopsies and surgical implants. There is a pressing clinical need to develop non-invasive, low-risk, time and cost efficient methods for improved diagnosis and treatment management. Our goal is to address this clinical need by developing an efficient MR imaging acquisition and post-processing framework to provide non-invasive, fast and comprehensive information for clinical decision support.

Ongoing work focuses on:

• Magnetic Resonance Fingerprinting (MRF). MRF is a novel quantitative MR imaging technique developed in our lab which permits non-invasive quantification of multiple tissue properties within clinically feasible time.
• Multi-parametric MR acquisition, reconstruction, signal modeling and post-processing.
• Clinical translation of MR Fingerprinting in early detection and characterization of neurological diseases such as epilepsy, brain tumors, and multiple sclerosis.

Four positions open, please contact me dxm302@case.edu or meet me at ISMRM in Toronto !  Two postdocs on tissue microstructure imaging and diffusion. One Siemens full time employee on MR Fingerprinting clinical translation, and one postdoc on AI-based qMR for tumor prediction.